|
AU561343B2
(en)
|
1981-10-19 |
1987-05-07 |
Genentech Inc. |
Human immune interferon by recombinant dna
|
|
EP0091539B2
(en)
|
1982-03-31 |
1996-11-27 |
Ajinomoto Co., Inc. |
Gene coding for interleukin-2 polypeptide, recombinant DNA carrying said gene, cell lines possessing the recombinant DNA,and method for producing interleukin-2 using said cells
|
|
US4966843A
(en)
|
1982-11-01 |
1990-10-30 |
Cetus Corporation |
Expression of interferon genes in Chinese hamster ovary cells
|
|
US4892743A
(en)
|
1983-12-21 |
1990-01-09 |
Schering Corporation |
Novel hybrid interferon species
|
|
EP0165942A1
(en)
|
1983-12-23 |
1986-01-02 |
Monash University |
PRODUCTION OF HUMAN INTERFERON-$g(a)
|
|
AU594014B2
(en)
|
1984-03-21 |
1990-03-01 |
Research Corporation Technologies, Inc. |
Recombinant DNA molecules
|
|
JPS63500636A
(ja)
|
1985-08-23 |
1988-03-10 |
麒麟麦酒株式会社 |
多分化能性顆粒球コロニー刺激因子をコードするｄｎａ
|
|
US4810643A
(en)
|
1985-08-23 |
1989-03-07 |
Kirin- Amgen Inc. |
Production of pluripotent granulocyte colony-stimulating factor
|
|
US5017691A
(en)
|
1986-07-03 |
1991-05-21 |
Schering Corporation |
Mammalian interleukin-4
|
|
US5116742A
(en)
|
1986-12-03 |
1992-05-26 |
University Patents, Inc. |
RNA ribozyme restriction endoribonucleases and methods
|
|
WO1990006370A1
(en)
|
1988-12-01 |
1990-06-14 |
The Trustees Of The University Of North Carolina |
Synthetic interleukin-6
|
|
US5225337A
(en)
|
1989-09-25 |
1993-07-06 |
Innovir Laboratories, Inc. |
Ribozyme compositions and methods for use
|
|
US5246921A
(en)
|
1990-06-26 |
1993-09-21 |
The Wistar Institute Of Anatomy And Biology |
Method for treating leukemias
|
|
US5780036A
(en)
|
1991-08-26 |
1998-07-14 |
The Scripps Research Institute |
Peptides for inducing cytotoxic T lymphocyte responses to hepattis B virus
|
|
WO1995003777A1
(en)
|
1993-08-02 |
1995-02-09 |
The Scripps Research Institute |
Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
|
|
SE9401709D0
(sv)
*
|
1994-05-18 |
1994-05-18 |
Mathilda Sjoeberg |
Improved alphavirus vectors for expression of heterologous DNA
|
|
US5792462A
(en)
|
1995-05-23 |
1998-08-11 |
University Of North Carolina At Chapel Hill |
Alphavirus RNA replicon systems
|
|
US6041252A
(en)
|
1995-06-07 |
2000-03-21 |
Ichor Medical Systems Inc. |
Drug delivery system and method
|
|
DE19712889A1
(de)
|
1997-03-27 |
1998-10-01 |
Bosch Gmbh Robert |
Verfahren und Vorrichtung zur Ermittlung einer den Systemdruck in einem Bremskreis beschreibenden Größe
|
|
AU733628B2
(en)
|
1997-04-03 |
2001-05-17 |
Electrofect As |
Method for introducing pharmaceutical drugs and nucleic acids into skeletal muscle
|
|
US6261281B1
(en)
|
1997-04-03 |
2001-07-17 |
Electrofect As |
Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
|
|
US5873849A
(en)
|
1997-04-24 |
1999-02-23 |
Ichor Medical Systems, Inc. |
Electrodes and electrode arrays for generating electroporation inducing electrical fields
|
|
GB0023203D0
(en)
|
2000-09-21 |
2000-11-01 |
Isis Innovation |
Vaccination method
|
|
US6117660A
(en)
|
1997-06-10 |
2000-09-12 |
Cytopulse Sciences, Inc. |
Method and apparatus for treating materials with electrical fields having varying orientations
|
|
JP2002507985A
(ja)
|
1997-06-30 |
2002-03-12 |
ローヌ−プーラン・ロレ・エス・アー |
横紋筋に核酸を導入する改良法およびその組合せ
|
|
US5958060A
(en)
|
1998-01-02 |
1999-09-28 |
General Electric Company |
Method and apparatus for clock control and synchronization
|
|
US20020164585A1
(en)
*
|
1998-01-16 |
2002-11-07 |
Sean Chapman |
Method for enhancing RNA or protein production using non-native 5' untranslated sequences in recombinant viral nucleic acids
|
|
CA2337652C
(en)
|
1998-07-13 |
2013-03-26 |
Genetronics, Inc. |
Skin and muscle-targeted gene therapy by pulsed electrical field
|
|
US6319901B1
(en)
|
1998-10-15 |
2001-11-20 |
Ichor Medical Systems, Inc. |
Methods for prolonging cell membrane permeability
|
|
AU6235000A
(en)
*
|
1999-07-21 |
2001-02-13 |
Large Scale Biology Corporation |
Method for enhancing rna or protein production using non-native 5' untranslated sequences in recombinant viral nucleic acids
|
|
US20040213805A1
(en)
|
1999-10-12 |
2004-10-28 |
Verheije Monique Helene |
Deletions in arterivirus replicons
|
|
WO2002095040A1
(en)
|
2001-05-21 |
2002-11-28 |
Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. |
Delections in arterivirus replicons
|
|
AU2001290642A1
(en)
|
2000-09-07 |
2002-03-22 |
University Of North Carolina At Chapel Hill |
Vectors derived from south african arbovirus no. 86
|
|
US6538922B1
(en)
|
2000-09-27 |
2003-03-25 |
Sandisk Corporation |
Writable tracking cells
|
|
EP1195438A1
(en)
*
|
2000-10-06 |
2002-04-10 |
Rijksuniversiteit te Groningen |
Genetic immunisation against cervical carcinoma
|
|
HU230198B1
(hu)
|
2000-11-23 |
2015-10-28 |
Bavarian Nordic A/S |
Módosított Vacciniavírus Ankara-variáns
|
|
WO2002061113A2
(en)
|
2001-02-01 |
2002-08-08 |
The Johns Hopkins University |
Nucleic acid derived vaccine that encodes an antigen linked to a polypeptide that promotes antigen presentation
|
|
DE60126595D1
(de)
|
2001-07-19 |
2007-03-29 |
Ericsson Telefon Ab L M |
Verfahren und Vorrichtung für die Lösung der Nummernübertragbarkeit am Ursprungsort
|
|
US7204997B2
(en)
|
2002-01-29 |
2007-04-17 |
Supratek Pharma Inc. |
Responsive microgel and methods related thereto
|
|
US7245963B2
(en)
|
2002-03-07 |
2007-07-17 |
Advisys, Inc. |
Electrode assembly for constant-current electroporation and use
|
|
US8209006B2
(en)
|
2002-03-07 |
2012-06-26 |
Vgx Pharmaceuticals, Inc. |
Constant current electroporation device and methods of use
|
|
US6912417B1
(en)
|
2002-04-05 |
2005-06-28 |
Ichor Medical Systmes, Inc. |
Method and apparatus for delivery of therapeutic agents
|
|
US7328064B2
(en)
|
2002-07-04 |
2008-02-05 |
Inovio As |
Electroporation device and injection apparatus
|
|
US6943015B2
(en)
*
|
2002-12-12 |
2005-09-13 |
Ilya Frolov |
Large scale production of packaged alphavirus replicons
|
|
EP1593738A4
(en)
*
|
2003-01-30 |
2006-05-31 |
Shanghai Tengen Biomedical Co |
VIRUSELY PARTICULATE VACCINE WITH RECOMBINANT DENGUEVIRUS REPLICANT AS ITS SUPPORT
|
|
US8080255B2
(en)
|
2003-07-11 |
2011-12-20 |
Novavax Inc. |
Functional influenza virus like particles (VLPs)
|
|
ATE432285T1
(de)
|
2003-07-11 |
2009-06-15 |
Alphavax Inc |
Cytomegalovirusimpfstoffe, die auf dem alphavirus basieren
|
|
WO2005026316A2
(en)
*
|
2003-09-15 |
2005-03-24 |
Bioption Ab |
Alphavirus vaccines
|
|
US20050070700A1
(en)
|
2003-09-30 |
2005-03-31 |
Matthias Giese |
Equine arteritis virus vaccine
|
|
US20050171044A1
(en)
*
|
2003-12-24 |
2005-08-04 |
Stein David A. |
Oligonucleotide compound and method for treating nidovirus infections
|
|
HUE025052T2
(en)
|
2004-03-08 |
2016-01-28 |
Ichor Medical Systems Inc |
A sharpened device for electrically mediated delivery of medical substances
|
|
CA2567254C
(en)
|
2004-05-18 |
2012-03-13 |
Alphavax, Inc. |
Tc-83-derived alphavirus vectors, particles and methods
|
|
US7862829B2
(en)
*
|
2004-07-09 |
2011-01-04 |
University Of North Carolina At Chapel Hill |
Viral adjuvants
|
|
KR100872840B1
(ko)
*
|
2004-07-09 |
2008-12-22 |
(주)씨아이디 |
돼지생식기호흡기증후군 바이러스에 대한 전체-길이의감염성이 있는 cDNA 클론 및 이의 용도
|
|
EP1945247A1
(en)
|
2005-10-18 |
2008-07-23 |
Novartis Vaccines and Diagnostics, Inc. |
Mucosal and systemic immunizations with alphavirus replicon particles
|
|
EP1792996A1
(en)
*
|
2005-12-01 |
2007-06-06 |
Consejo Superior de Investigaciones Cientificas |
Nucleic acid sequences encoding vaccines against Porcine reproductive and respiratory syndrome virus (PRRSV)
|
|
US8859198B2
(en)
|
2006-06-06 |
2014-10-14 |
Abl Sa |
Detection and use of antiviral resistance mutations
|
|
US20120121650A1
(en)
|
2006-08-18 |
2012-05-17 |
Johnston Robert E |
Chimeric Virus Vaccines
|
|
KR101421760B1
(ko)
|
2006-10-17 |
2014-07-22 |
브이지엑스 파머시우티컬즈, 인크. |
포유류의 세포의 전기천공용 전기천공 장치 및 이의 사용 방법
|
|
EP2097538A4
(en)
|
2006-12-07 |
2011-11-30 |
Switchgear Genomics |
TRANSCRIPTION REAGULATION ELEMENTS OF BIOLOGICAL PATHS, TOOLS AND METHODS
|
|
KR100836745B1
(ko)
|
2007-01-31 |
2008-06-10 |
(주)두비엘 |
Ｈｂｖ 백신 및 그의 제조 방법
|
|
PL2947149T3
(pl)
|
2007-06-21 |
2018-09-28 |
Alphavax, Inc. |
Kasety bez promotora do ekspresji alfawirusowych białek strukturalnych
|
|
EP2222336A2
(en)
|
2007-10-29 |
2010-09-01 |
GENimmune N.V. |
Methods and kits for inducing a ctl response using a prime boost regimen
|
|
US20110300205A1
(en)
|
2009-07-06 |
2011-12-08 |
Novartis Ag |
Self replicating rna molecules and uses thereof
|
|
MX2012001592A
(es)
|
2009-08-07 |
2012-05-22 |
Transgene Sa |
Composicion para el tratamiento de la infección del virus de la hepatitis b.
|
|
US9101572B2
(en)
*
|
2009-12-31 |
2015-08-11 |
Medigen, Inc. |
Infectious DNA vaccines against chikungunya virus
|
|
ES2646669T3
(es)
|
2010-07-06 |
2017-12-14 |
Glaxosmithkline Biologicals Sa |
Procedimientos de aumento de una respuesta inmunitaria mediante el suministro de ARN
|
|
WO2012087983A1
(en)
|
2010-12-20 |
2012-06-28 |
The General Hospital Corporation |
Polycomb-associated non-coding rnas
|
|
AU2012214141B2
(en)
|
2011-02-11 |
2016-01-28 |
The Trustees Of The University Of Pennsylvania |
Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same
|
|
KR102171142B1
(ko)
|
2011-06-28 |
2020-10-28 |
이노비오 파마수티컬즈, 인크. |
최소 침습 피부 전기천공 장치
|
|
TWI575070B
(zh)
|
2011-07-12 |
2017-03-21 |
傳斯堅公司 |
Ｈｂｖ聚合酶突變體
|
|
WO2013120499A1
(en)
*
|
2012-02-15 |
2013-08-22 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly (a) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
|
|
PL2814962T3
(pl)
*
|
2012-02-15 |
2018-11-30 |
Curevac Ag |
Kwas nukleinowy zawierający lub kodujący histonowy trzonek-pętlę i sekwencję poli(A) lub sygnał poliadenylacji do zwiększania ekspresji zakodowanego antygenu patogennego
|
|
US8961995B2
(en)
*
|
2012-09-20 |
2015-02-24 |
Uab Research Foundation |
Methods and compositions for alphavirus replicons
|
|
JP6240090B2
(ja)
|
2012-12-13 |
2017-11-29 |
パナソニックヘルスケアホールディングス株式会社 |
薬剤注入装置
|
|
WO2014170493A2
(en)
|
2013-04-19 |
2014-10-23 |
Novartis Ag |
Alphavirus vector
|
|
AU2014310935B2
(en)
|
2013-08-21 |
2019-11-21 |
CureVac SE |
Combination vaccine
|
|
EP3164420A4
(en)
|
2014-06-30 |
2018-05-23 |
Tarveda Therapeutics, Inc. |
Targeted conjugates and particles and formulations thereof
|
|
WO2016020538A1
(en)
|
2014-08-08 |
2016-02-11 |
Transgene Sa |
Hbv vaccine and antibody combination therapy to treat hbv infections
|
|
AU2015323944B2
(en)
|
2014-10-01 |
2018-11-29 |
Inovio Pharmaceuticals, Inc. |
Vaccines having an antigen and interleukin-21 as an adjuvant
|
|
HRP20220893T1
(hr)
*
|
2015-04-08 |
2022-10-14 |
Novartis Ag |
Cd20 terapije, cd22 terapije, i kombinirane terapije sa stanicom koja eksprimira cd19 kimerni antigenski receptor
|
|
AU2016264027A1
(en)
|
2015-05-15 |
2017-08-31 |
Curevac Ag |
Prime-boost regimens involving administration of at least one mRNA construct
|
|
JP7048482B2
(ja)
|
2015-08-03 |
2022-04-05 |
アメリカ合衆国 |
Ｂｒａｃｈｙｕｒｙ欠失変異体、Ｂｒａｃｈｙｕｒｙ欠失変異体をコードする非酵母ベクター、及びそれらの使用
|
|
EA038691B1
(ru)
|
2016-03-28 |
2021-10-05 |
Айкор Медикэл Системс, Инк. |
Устройство для доставки терапевтических средств
|
|
WO2017176319A1
(en)
|
2016-04-06 |
2017-10-12 |
University Of Washington |
Therapeutic vaccine for hepatitis b virus (hbv) using the hbv core antigen
|
|
US10538786B2
(en)
|
2016-04-13 |
2020-01-21 |
Janssen Pharmaceuticals, Inc. |
Recombinant arterivirus replicon systems and uses thereof
|
|
MX2019004499A
(es)
|
2016-10-17 |
2019-11-18 |
Janssen Pharmaceuticals Inc Star |
Sistemas de replicón de virus recombinante y usos de estos.
|
|
AU2017372731B2
(en)
|
2016-12-05 |
2024-05-23 |
Janssen Pharmaceuticals, Inc. |
Compositions and methods for enhancing gene expression
|
|
EP3607968A4
(en)
|
2017-06-05 |
2021-03-31 |
Beacle Inc. |
VIRAL-TYPE PARTICLES INTENDED FOR USE TO INDUCE AN IMMUNE RESPONSE AGAINST HBV
|
|
WO2019099624A1
(en)
|
2017-11-16 |
2019-05-23 |
University Of Washington |
A therapeutic vaccine for hepatitis b virus (hbv) using the hbv pres1 and/or pres2, and/or s-hbsag regions of the hbv envelope protein
|
|
EA202091513A1
(ru)
|
2017-12-19 |
2020-09-09 |
Янссен Сайенсиз Айрлэнд Анлимитед Компани |
Вакцины против вируса гепатита b (hbv) и их применение
|
|
KR20200101416A
(ko)
|
2017-12-19 |
2020-08-27 |
얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 |
B형 간염 바이러스(hbv) 백신 및 그 용도
|